Literature DB >> 29735191

Can Technological Improvements Reduce the Cost of Proton Radiation Therapy?

Jacobus Maarten Schippers1, Anthony Lomax2, Adriano Garonna3, Katia Parodi4.   

Abstract

In recent years there has been increasing interest in the more extensive application of proton therapy in a clinical and preferably hospital-based environment. However, broader adoption of proton therapy has been hindered by the costs of treatment, which are still much higher than those in advanced photon therapy. This article presents an overview of on-going technical developments, which have a reduction of the capital investment or operational costs either as a major goal or as a potential outcome. Developments in instrumentation for proton therapy, such as gantries and accelerators, as well as facility layout and efficiency in treatment logistics will be discussed in this context. Some of these developments are indeed expected to reduce the costs. The examples will show, however, that a dramatic cost reduction of proton therapy is not expected in the near future. Although current developments will certainly contribute to a gradual decrease of the treatment costs in the coming years, many steps will still have to be made to achieve a much lower cost per treatment.
Copyright © 2018. Published by Elsevier Inc.

Mesh:

Year:  2018        PMID: 29735191     DOI: 10.1016/j.semradonc.2017.11.007

Source DB:  PubMed          Journal:  Semin Radiat Oncol        ISSN: 1053-4296            Impact factor:   5.934


  9 in total

Review 1.  The Role of Hypofractionation in Proton Therapy.

Authors:  Alexandre Santos; Scott Penfold; Peter Gorayski; Hien Le
Journal:  Cancers (Basel)       Date:  2022-05-02       Impact factor: 6.575

2.  Comparative toxicity outcomes of proton-beam therapy versus intensity-modulated radiotherapy for prostate cancer in the postoperative setting.

Authors:  Patricia Mae G Santos; Andrew R Barsky; Wei-Ting Hwang; Curtiland Deville; Xingmei Wang; Stefan Both; Justin E Bekelman; John P Christodouleas; Neha Vapiwala
Journal:  Cancer       Date:  2019-09-10       Impact factor: 6.860

Review 3.  Proton therapy for brain tumours in the area of evidence-based medicine.

Authors:  Damien C Weber; Pei S Lim; Sebastien Tran; Marc Walser; Alessandra Bolsi; Ulrike Kliebsch; Jürgen Beer; Barbara Bachtiary; Tony Lomax; Alessia Pica
Journal:  Br J Radiol       Date:  2019-05-20       Impact factor: 3.039

Review 4.  Technology-driven research for radiotherapy innovation.

Authors:  Claudio Fiorino; Matthias Guckemberger; Marco Schwarz; Uulke A van der Heide; Ben Heijmen
Journal:  Mol Oncol       Date:  2020-03-19       Impact factor: 6.603

5.  Three discipline collaborative radiation therapy (3DCRT) special debate: The United States should build additional proton therapy facilities.

Authors:  Steve Braunstein; Li Wang; Wayne Newhauser; Todd Tenenholz; Yi Rong; Albert van der Kogel; Michael Dominello; Michael C Joiner; Jay Burmeister
Journal:  J Appl Clin Med Phys       Date:  2019-02-08       Impact factor: 2.102

6.  Long-Term Medical Resource Consumption of Radical Prostatectomy vs. Intensity-Modulated Radiotherapy for Old Patients With Prostate Cancer: A Nationwide Population-Based Cohort Study.

Authors:  Szu-Yuan Wu; Fransisca Fortunata Effendi; Jhao Yang Peng; Chung-Chien Huang
Journal:  Front Med (Lausanne)       Date:  2022-05-03

Review 7.  Treatment-integrated imaging, radiomics, and personalised radiotherapy: the future is at hand.

Authors:  Julian Malicki; Tomasz Piotrowski; Ferran Guedea; Marco Krengli
Journal:  Rep Pract Oncol Radiother       Date:  2022-09-19

Review 8.  Future Developments in Charged Particle Therapy: Improving Beam Delivery for Efficiency and Efficacy.

Authors:  Jacinta Yap; Andrea De Franco; Suzie Sheehy
Journal:  Front Oncol       Date:  2021-12-09       Impact factor: 5.738

9.  Cost-Effectiveness Models of Proton Therapy for Head and Neck: Evaluating Quality and Methods to Date.

Authors:  Danmeng Huang; Steven J Frank; Vivek Verma; Nikhil G Thaker; Eric D Brooks; Matthew B Palmer; Ross F Harrison; Ashish A Deshmukh; Matthew S Ning
Journal:  Int J Part Ther       Date:  2021-06-25
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.